Skip to main content Help with accessibility Skip to main navigation

Direct Oral Anticoagulants (DOACs) (previously known as NOACs) in Non Valvular Atrial Fibrillation: a multiple prescribing statement for Apixaban, Dabigatran, Edoxaban and Rivaroxaban

CCG Approval Status:

Date Added: 24 - Oct - 2019
Body System:

DOACs are recommended as treatment options for the prevention of stroke and systemic emboli in non-valvular atrial fibrillation where an oral anticoagulant is indicated.